The FDA has granted Fast Track designation for SAB Biotherapeutics' SABS SAB-176, an investigational therapeutic for Type A and Type B influenza illness in high-risk patients, including those who have ...

Stock Score Locked: Want to See it? Benzinga Rankings give you vital metrics on any stock – anytime.

Nearly a year after a public cheating scandal tore them apart, Jaden Smith and his ex-girlfriend Sab Zada have sparked ...

Participation from strategic investor Sanofi, along with new investors RA Capital Management, Commodore Capital, Vivo Capital, Blackstone Multi-Asset Investing, Spruce Street Capital, Forge Life ...

SAB BIO has announced a $175 million private placement financing to fund its pivotal Phase 2b SAFEGUARD study of SAB-142, aimed at delaying the progression of autoimmune type 1 diabetes (T1D) in newly ...